Medication info
Selnapin Tablets (Terbinafine Hydrochloride)

Selnapin Tablets (Terbinafine Hydrochloride)

Prescription medicationTablet
Ingredient · strength
Terbinafine Hydrochloride›140.625mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
White round tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201900799 · Approved 2019.02.01 · Insurance code 693902950

Summary

Main use
Treatment of onychomycosis and cutaneous fungal infections (such as tinea pedis and tinea corporis), and tinea capitis
Who uses it
Adults · Children
Adult dosage
Administer terbinafine 125 mg twice daily or 250 mg once daily. The duration of treatment according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually given for 6 weeks~3 months. Infections of the fingernails or relatively small toenails, or in younger patients, may require a shorter treatment period of 3 months or less. A treatment period of 3 months is usually sufficient for toenail infections, but some patients may require 6 months or longer. Treatment may need to be longer in patients with slow nail growth. 3. Patients with renal impairment For patients with creatinine clearance less than 50 mL/min, reduce the daily dose by 1/2.
Children's dosage
Administer to children aged 2 years and older. Use is not recommended in children under 2 years of age because there is no experience with administration in this age group. Tinea capitis: 4 weeks Tinea capitis occurs primarily in children. To prevent recurrence of infection, treatment should be administered regularly for the appropriate prescribed duration. 1) Body weight under 20 kg (under 5 years): 62.5 mg once daily. Because experience with treatment is limited, the decision to treat should be based on consideration of the benefits and risks. 2) Body weight 20~40 kg (5 years~12 years): 125 mg once daily. 3) Body weight over 40 kg (over 12 years): 250 mg once daily.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of onychomycosis and cutaneous fungal infections (such as tinea pedis and tinea corporis), and tinea capitis

  • Dermatophyte infection
  • athlete's foot
  • ringworm
  • tinea capitis
  • onychomycosis
View approved original text

This medication is used to treat athlete's foot, ringworm, tinea capitis, and onychomycosis caused by dermatophyte fungi in adults. It is also effective in treating tinea capitis in children. In other words, it is used to treat fungal infections of the skin and nails.

Dosage and Administration

Adult dosage

Administer terbinafine 125 mg twice daily or 250 mg once daily. The duration of treatment according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually given for 6 weeks~3 months. Infections of the fingernails or relatively small toenails, or in younger patients, may require a shorter treatment period of 3 months or less. A treatment period of 3 months is usually sufficient for toenail infections, but some patients may require 6 months or longer. Treatment may need to be longer in patients with slow nail growth. 3. Patients with renal impairment For patients with creatinine clearance less than 50 mL/min, reduce the daily dose by 1/2.

Children's dosage

Administer to children aged 2 years and older. Use is not recommended in children under 2 years of age because there is no experience with administration in this age group. Tinea capitis: 4 weeks Tinea capitis occurs primarily in children. To prevent recurrence of infection, treatment should be administered regularly for the appropriate prescribed duration. 1) Body weight under 20 kg (under 5 years): 62.5 mg once daily. Because experience with treatment is limited, the decision to treat should be based on consideration of the benefits and risks. 2) Body weight 20~40 kg (5 years~12 years): 125 mg once daily. 3) Body weight over 40 kg (over 12 years): 250 mg once daily.

Precautions

This medicine is not recommended for patients with chronic liver disease or active liver disease. Make sure to check if there is a history of liver disease before administration and conduct regular liver function tests. If symptoms of liver dysfunction appear, discontinue the medication immediately and consult a doctor. This medication can cause serious liver damage, such as liver failure, so caution is required. This medication should not be administered to patients with allergies to this medicine or its components, patients with chronic liver disease, hematological disorders, severe renal failure, nursing mothers, infants under 2 years of age, or patients with certain genetic lactose intolerance. Caution should be exercised when administering to patients with impaired renal function, elderly patients, children weighing less than 20 kg, psoriasis, or systemic lupus erythematosus patients, and if serious skin reactions occur, the medication should be discontinued immediately. This medication can cause various side effects such as liver dysfunction, blood disorders, skin rashes, muscle pain, gastrointestinal symptoms, mental changes, and neurological abnormalities; therefore, if any abnormal symptoms appear, notify a doctor immediately. Caution is needed when driving or operating machinery as dizziness and other side effects may occur. This medication may interact with other drugs, requiring dosage adjustments and caution during concomitant use. In particular, when used together with medications metabolized in the liver, follow your doctor's instructions. Women who are pregnant or may become pregnant should use this medication cautiously, and nursing mothers should discontinue breastfeeding while using it. Experience in administering to infants under 2 years is lacking, hence not recommended. Care should be taken when administering to children and the elderly. In case of overdose, symptoms may include headache, nausea, abdominal pain, and dizziness, requiring immediate medical attention. Store this medicine out of reach of children and keep it in a tightly closed container, avoiding direct sunlight and storing it at room temperature.

Side effects

Liver and biliary dysfunction, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, malaise, γ-GTP elevation, AST/ALT elevation, LDH elevation, ALP elevation, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, petechiae, leukopenia, anemia, rash, itching, phototoxic reaction, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, bullous dermatitis, psoriasis-like rash, psoriasis exacerbation, hair loss, musculoskeletal reactions, arthralgia, myalgia, weakness, CPK elevation, rhabdomyolysis, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangiectasia, abdominal distension, decreased appetite, dyspepsia, mild abdominal pain, diarrhea, discomfort in the upper abdomen, thirst, vomiting, glossitis, depression, anxiety, headache, taste disturbance, dizziness, drowsiness, paresthesia, sensory loss, decreased attention, insomnia, BUN elevation, polyuria, visual disturbances, tinnitus, anaphylactic-like reaction, angioedema, systemic lupus erythematosus, increased total cholesterol in the blood, increased triglycerides, malaise, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, decreased vision, hearing loss, auditory impairment, vasculitis, permanent loss of smell, anosmia, hyposmia, drug rash accompanied by eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, increased blood creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medicine in a tightly closed container to prevent exposure to air, ideally at room temperature between 1 to 30 degrees Celsius. This way, the effectiveness of the medication can be well maintained.

Appearance and packaging

Appearance

White round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.